News

COVID-19's propensity to fuel domestic drug production hasn't waned two years into the pandemic. Take, for example, Pfizer's new $120 million investment. The company announced on June 6 that it will use the funds to expand manufacturing of its oral...

Even though the company's analysis found it could reduce the likelihood of mild-to-severe disease, the US Food and Drug Administration has expressed concern about a potential hazard of heart inflammation from Novavax Inc's COVID-19 vaccine. Within 20 days of receiving...

The top 300 brands of drugs, including commonly used analgesics, vitamin supplements, anti-platelet medicines, pain relievers, blood-sugar-lowering medicines, and contraceptive tablets, have been shortlisted by India's drug pricing authority and will be required to add QR codes to their packages in...

India has set a massive effort to reduce its reliance on China for crucial raw materials as part of its drive to become the world's "pharmacy." India, which is already the world's third-largest producer of drugs by quantity, has one...

While the COVID-19 outbreak prompted the development of novel antibody medicines and vaccinations, scientists have discovered that current medications can occasionally aid patients in their fight against the virus. A clinically meaningful trial on rheumatoid arthritis medicines in hospitalised...

In a deal worth up to $3.3 billion, GlaxoSmithKline (GSK) has reached a formal agreement to buy 100% of the outstanding shares of Affinivax, a clinical-stage biopharmaceutical company based in the United States. GSK will make an initial payment...

Peli BioThermal, the life science industry’s partner from discovery to distribution, recently concluded its InnovationShare webinar series. Launched in March 2021, InnovationShare was designed to fill the in-person learning gap during the height of the COVID-19 pandemic. Webinars brought...